Initial Clinical and CBCT Outcomes of Enamel Matrix Derivative-Based Regenerative Therapy in Vertical Bone Defects
1 other identifier
interventional
48
1 country
1
Brief Summary
Study of the effectiveness of the application of regenerative therapy with autogenous, platelet-rich plasma in vertical defects Investigation of the effectiveness of the application of regenerative therapy with enamel matrix derivatives in vertical bone defects Study of the effectiveness of the application of guided tissue regeneration in vertical bone defects with Barrier membrane and Barrier membrane and autogenous platelet-rich plasma
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2023
CompletedFirst Submitted
Initial submission to the registry
October 9, 2024
CompletedFirst Posted
Study publicly available on registry
October 15, 2024
CompletedOctober 15, 2024
October 1, 2024
8 months
October 9, 2024
October 10, 2024
Conditions
Outcome Measures
Primary Outcomes (6)
Probing depth in mm
6 months
Level of Margo Gingivalis in mm
6 months
Clinical attachment level in mm
6 months
The distance from the ECJ to the base of the bone defect in mm
6 months
The distance from the ECJ to the apex of the bone defect in mm
6 months
The width of the bone defect in mm
6 months
Study Arms (4)
PRP alone
ACTIVE COMPARATOREMD Alone
ACTIVE COMPARATORGTR (barrier membrane)
ACTIVE COMPARATORGTR(barrier membrane and PRP)
ACTIVE COMPARATORInterventions
regenerative therapy with EMD for vertical bone defects
guided tissue regeneration with barrier membrane alone for vertical bone defects
guided tissue regeneration with barrier membrane and PRP for vertical bone defects
Eligibility Criteria
You may qualify if:
- good oral hygiene
- written informed consent
- age
- no systemic diseases
You may not qualify if:
- smokers
- horizontal bone loss
- untreated periodontium disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University - Varna
Varna, Varna, 9000, Bulgaria
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant
Study Record Dates
First Submitted
October 9, 2024
First Posted
October 15, 2024
Study Start
June 24, 2022
Primary Completion
February 15, 2023
Study Completion
August 15, 2023
Last Updated
October 15, 2024
Record last verified: 2024-10